Form 4 Tracker
Andrew Oxtoby

Director, President and Chief Executive Officer · 1 filing · Latest: Mar 19, 2026

Kalaris Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing